MAXWELL KLINE: Open Payments
NPI 1790535862 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$413 in 17 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $413
Food & beverage: $413
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $199 |
| Janssen Biotech, Inc. | 3 | $71 |
| GlaxoSmithKline, LLC. | 3 | $67 |
| KYOWA KIRIN, INC. | 2 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
Products named: RINVOQ, TREMFYA, BENLYSTA, CRYSVITA, OFEV.
Industry payments across CA — which companies pay providers there.
